生长抑素治疗肠梗阻的临床研究

Clinical Research of Somatostatin in Treatment With Intestinal Obstruction

目的探讨生长抑素治疗肠梗阻的临床效果。方法肠梗阻患者100例,将其随机分为观察组与对照组。对照组患者50例,行常规治疗,包括禁食、胃肠道减压治疗等;观察组患者50例,在此基础上加以生长抑素对患者进行治疗。若保守治疗无效,则为患者中转手术治疗。比较两组患者的治疗效果及中转手术治疗率。结果观察组患者治疗效果优于对照组,两组患者治疗有效率存在显著差异(P<0.05)。同时,观察组患者胃肠减压量与对照组患者也存在显著差异(P<0.05)。结论在常规治疗基础上联合生长抑素治疗肠梗阻具有较好的临床效果,安全性也较高。

ObjectiveTo study the effect of somatostatin in the treatment of intestinal obstruction.Methods 100 cases patients with intestinal obstruction,it were randomly divided into observation group and control group. The control group,50 cases of patients with routine treatment,including fasting, gastrointestinal decompression treatment,etc; Observation group of 50 cases of patients,on the basis of somatostatin treating patients. If conservative treatment is invalid,the interim surgical treatment for patients. Compare the therapeutic effect of two groups of patients and transit operation treatment. Results The observation group of patients treatment is better than the control group,two groups of patients efficient significant differences（P〈0.05）.At the same time,the observation group of patients with gastrointestinal decompression and the control group patients are significantly different（P〈0.05）. Conclusion On the basis of conventional treatment combined somatostatin treatment of intestinal obstruction has good clinical effect,high safety.